New eye injection aims to halt vision loss in dry AMD
NCT ID NCT06087458
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage trial is testing a new drug called VOY-101 for people with advanced dry age-related macular degeneration (AMD) and geographic atrophy, a condition that causes blind spots. The drug is injected into the eye and aims to slow damage to the retina and preserve vision. The study will enroll 60 participants aged 60 and older to evaluate safety and effectiveness.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- VOY-101 (a biologic drug injected into the eye)
- What this could lead to
- If successful, this could lead to a treatment that slows or stops the progression of geographic atrophy in dry age-related macular degeneration, preserving vision.
- What could go wrong
- This is an early-phase trial with only 60 participants, so results may not apply to everyone. The drug is injected into the eye, which carries risks like infection or inflammation, and it may not slow vision loss as hoped.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGE-RELATED MACULAR DEGENERATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Cerulea Clinical Trials
ACTIVE_NOT_RECRUITINGEast Melbourne, Victoria, 3002, Australia
-
Rambam Medical Center
RECRUITINGHaifa, Israel
-
Retina Center of Texas
RECRUITINGSouthlake, Texas, 76092, United States
-
Retina Consultants San Diego
RECRUITINGSan Diego, California, 92064, United States
-
Retina Macula Institute of AZ
RECRUITINGScottsdale, Arizona, 85255, United States
-
Retinal Consultants Medical Group
RECRUITINGSacramento, California, 95825, United States
-
Star Retina
RECRUITINGBurleson, Texas, 76028, United States
-
Sydney Retina Clinic and Day Surgery
ACTIVE_NOT_RECRUITINGSydney, New South Wales, 2000, Australia
-
Tel-Aviv Sourasky Medical Center, Ophthalmology Division
RECRUITINGTel Aviv, 64239, Israel
-
The Retina Partners
RECRUITINGEncino, California, 91436, United States
-
University of Utah John A. Moran Eye Center
RECRUITINGSalt Lake City, Utah, 84132, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a VR maze reveal hidden vision loss in macular degeneration?
- New eye imaging could reveal hidden clues to vision loss
- Can a new eye injection save vision in wet AMD?
- A new eye camera may spot stressed cells before vision loss begins
- A sharper look at the retina: new imaging technology may spot eye disease earlier
- Eye injection aims to tame leading causes of blindness